| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
0.02 |
0.9 |
| mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |